Form 8-K - Current report:
SEC Accession No. 0001193805-23-000659
Filing Date
2023-05-04
Accepted
2023-05-04 06:49:21
Documents
76
Period of Report
2023-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618584_8k-immunic.htm   iXBRL 8-K 19298
2 e618584_ex99-1.htm EX-99.1 28347
3 e618584_ex99-2.htm EX-99.2 46131
7 GRAPHIC slide1.jpg GRAPHIC 284463
8 GRAPHIC slide2.jpg GRAPHIC 356659
9 GRAPHIC slide3.jpg GRAPHIC 144522
10 GRAPHIC slide4.jpg GRAPHIC 73195
11 GRAPHIC slide5.jpg GRAPHIC 142560
12 GRAPHIC slide6.jpg GRAPHIC 163969
13 GRAPHIC slide7.jpg GRAPHIC 91753
14 GRAPHIC slide8.jpg GRAPHIC 214862
15 GRAPHIC slide9.jpg GRAPHIC 125121
16 GRAPHIC slide10.jpg GRAPHIC 221628
17 GRAPHIC slide11.jpg GRAPHIC 135501
18 GRAPHIC slide12.jpg GRAPHIC 95542
19 GRAPHIC slide13.jpg GRAPHIC 127810
20 GRAPHIC slide14.jpg GRAPHIC 166335
21 GRAPHIC slide15.jpg GRAPHIC 117458
22 GRAPHIC slide16.jpg GRAPHIC 205424
23 GRAPHIC slide17.jpg GRAPHIC 101621
24 GRAPHIC slide18.jpg GRAPHIC 161754
25 GRAPHIC slide19.jpg GRAPHIC 147829
26 GRAPHIC slide20.jpg GRAPHIC 134540
27 GRAPHIC slide21.jpg GRAPHIC 131388
28 GRAPHIC slide22.jpg GRAPHIC 130298
29 GRAPHIC slide23.jpg GRAPHIC 103575
30 GRAPHIC slide24.jpg GRAPHIC 119803
31 GRAPHIC slide25.jpg GRAPHIC 115305
32 GRAPHIC slide26.jpg GRAPHIC 114704
33 GRAPHIC slide27.jpg GRAPHIC 100080
34 GRAPHIC slide28.jpg GRAPHIC 148944
35 GRAPHIC slide29.jpg GRAPHIC 161341
36 GRAPHIC slide30.jpg GRAPHIC 103942
37 GRAPHIC slide31.jpg GRAPHIC 76371
38 GRAPHIC slide32.jpg GRAPHIC 79403
39 GRAPHIC slide33.jpg GRAPHIC 89902
40 GRAPHIC slide34.jpg GRAPHIC 133179
41 GRAPHIC slide35.jpg GRAPHIC 135535
42 GRAPHIC slide36.jpg GRAPHIC 103916
43 GRAPHIC slide37.jpg GRAPHIC 216055
44 GRAPHIC slide38.jpg GRAPHIC 188724
45 GRAPHIC slide39.jpg GRAPHIC 105769
46 GRAPHIC slide40.jpg GRAPHIC 101374
47 GRAPHIC slide41.jpg GRAPHIC 106940
48 GRAPHIC slide42.jpg GRAPHIC 141346
49 GRAPHIC slide43.jpg GRAPHIC 177311
50 GRAPHIC slide44.jpg GRAPHIC 149642
51 GRAPHIC slide45.jpg GRAPHIC 144465
52 GRAPHIC slide46.jpg GRAPHIC 166686
53 GRAPHIC slide47.jpg GRAPHIC 96848
54 GRAPHIC slide48.jpg GRAPHIC 119658
55 GRAPHIC slide49.jpg GRAPHIC 94988
56 GRAPHIC slide50.jpg GRAPHIC 144880
57 GRAPHIC slide51.jpg GRAPHIC 119507
58 GRAPHIC slide52.jpg GRAPHIC 166990
59 GRAPHIC slide53.jpg GRAPHIC 123541
60 GRAPHIC slide54.jpg GRAPHIC 150938
61 GRAPHIC slide55.jpg GRAPHIC 139798
62 GRAPHIC slide56.jpg GRAPHIC 150031
63 GRAPHIC slide57.jpg GRAPHIC 164118
64 GRAPHIC slide58.jpg GRAPHIC 151029
65 GRAPHIC slide59.jpg GRAPHIC 158065
66 GRAPHIC slide60.jpg GRAPHIC 150145
67 GRAPHIC slide61.jpg GRAPHIC 147987
68 GRAPHIC image_001.jpg GRAPHIC 3196
  Complete submission text file 0001193805-23-000659.txt   12186243

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE imux-20230504_pre.xml EX-101.PRE 22351
5 XBRL LABEL FILE imux-20230504_lab.xml EX-101.LAB 34240
6 XBRL SCHEMA FILE imux-20230504.xsd EX-101.SCH 2947
70 EXTRACTED XBRL INSTANCE DOCUMENT e618584_8k-immunic_htm.xml XML 3809
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 23886327
SIC: 2834 Pharmaceutical Preparations